The first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan
The Drugs Controller General of India (DCGI) has granted the emergency use authorisation license to the country's Defence Research and Development Organisation (DRDO) for a drug to treat COVID-19 patients, officials said Saturday.
1714198961_80X80.jpg)
1714198961_480X320.jpg)
